Summary
Swedish researchers found everyone diagnosed with gender dysphoria in national health records between 2001 and 2023, about 9,000 people who were about 25 on average when diagnosed. They compared deaths with men and women of the same age and county. Over about seven years, 211 people with gender dysphoria died, almost twice the death rate of the comparison groups after allowing for age. Extra deaths came from accidents, violence and suicide (suicide was not counted on its own), from unclear causes, from mental and brain conditions such as drug or alcohol problems, and from cancer in people born female. The authors call for public health action but say the records cannot explain why. Nothing beyond age and county was taken into account, and many causes had very few deaths. So the study shows a gap in deaths but not what causes it.
Key findings
- Studien omfattade 9 038 personer som diagnostiserades med könsdysfori i Sverige 2001–2023 (4 181 födda som män, 4 857 födda som kvinnor), jämförda med 179 816 personer med samma ålder och län.
- Det förekom 211 dödsfall. Efter hänsyn till ålder var dödstalet 183 mot 96 per 10 000 personer och år, ungefär dubbelt så högt.
- Bland personer födda som män var dödstalen 2,3 gånger kvinnors och 1,6 gånger mäns, med fler dödsfall av olyckor, våld och självmord (3,2 och 2,5 gånger), oklara orsaker (cirka 5 gånger) och psykiska eller hjärnrelaterade tillstånd (3,6 och 2,6 gånger).
- Bland personer födda som kvinnor var dödstalen 2,1 gånger kvinnors och 1,7 gånger mäns, med fler dödsfall av olyckor, våld och självmord (2,2 och 1,5 gånger) och cancer (2,4 och 1,8 gånger).
- Självmord, mord och olyckor orsakade tillsammans 76 av de 211 dödsfallen (36 %), men självmord rapporterades inte separat.
- I genomsnitt kom varje dödsfall 6 år för tidigt för personer födda som män (jämfört med män) och 9 år för tidigt för personer födda som kvinnor (jämfört med kvinnor).
- Författarna säger att fynden är en startpunkt för att följa dödsfall, inte evidens om orsaker eller om behandlingens effekter.
Abstract
BACKGROUND: Transgender and gender-diverse (TGD) people experience elevated mortality risk, yet population-based estimates of cause-specific mortality remain limited. Prior studies have focused on narrow subgroups or outdated cohorts, leaving gaps in understanding current mortality disparities. Therefore, the purpose of this study is to quantify all-cause and cause-specific mortality among all TGD adults with a diagnosis of gender dysphoria in Sweden. METHODS: This cohort study provides national cause-specific mortality estimates among TGD adults in Sweden using registry data (2001-2023). TGD people were identified using ICD-10 codes for "gender dysphoria" and matched to approximately 10 cisgender controls of each sex by age and county. Age-standardized mortality rates, absolute mortality risk differences, mortality rate ratios (MRR), and years of potential life lost (YPLL) were calculated overall and stratified by sex assigned at birth. FINDINGS: A total of 9038 TGD people were identified, among them, 211 deaths were observed. All-cause mortality risk was almost twice that of the cisgender comparison group (MRR = 1.9, 95% confidence interval [CI] 1.7, 2.2). Stratified analyses showed distinct mortality patterns for transfeminine (assigned male sex at birth) and transmasculine (assigned female sex at birth) people, with higher risk from ill-defined diseases among transfeminine people (cisgender women as reference: MRR = 4.9, 95% CI 2.3, 10.3; cisgender men: MRR = 5.5, 95% CI 2.6, 11.4) and transmasculine people from neoplasms (cisgender women: MRR = 2.4, 95% CI 1.4, 4.1; cisgender men: MRR = 1.8, 95% CI 1.1, 3.1). These disparities resulted in a mean of 6.3 YPLL for transfeminine people compared to cisgender men and 9.0 YPLL for transmasculine people compared to cisgender women. INTERPRETATION: These findings highlight persistent health inequities and underscore the need for targeted public health interventions and an evaluation of data collection processes to improve health monitoring and support TGD populations in Sweden. FUNDING: The present study was funded by a Starting Grant (2023-01397) and a project grant (2021-01968) from the Swedish Research Council for Health, Working Life and Welfare (FORTE).
Conclusion
These findings highlight persistent health inequities and underscore the need for targeted public health interventions and an evaluation of data collection processes to improve health monitoring and support TGD populations in Sweden. The authors note that registry data cannot distinguish whether excess deaths result from biological factors, behavioural risks, systemic barriers or administrative biases. They state that future research linking clinical treatment records to mortality is required, and that the findings serve primarily as a baseline for monitoring mortality trends rather than evidence of specific causal pathways.